Reckitt Benckiser: Nutrition arm bruised amid baby formula litigation case Retail Like-for-like sales at its nutrition arm fell by 9.9 per cent to £591m, which more than offset growth of 7.1 per cent at its hygiene arm and one per cent at its health arm.
Shares in Durex maker Reckitt flop as firm misses expectations Retail Shares in Durex condom maker Reckitt Benckiser have flopped over nine per cent after the firm missed analyst expectations and revenues showed signs of slowing.
Indivior plans primary US listing in another hit to London’s flagging equity market Not another one While the firm said it would look to maintain a secondary listing in the UK, the decision to shift its primary listing marks a big change for the company.